India’s IVF Sector Gets Boost: Iswarya Fertility Center Raises $37 Million

India’s IVF industry has landed one of its largest growth investments yet, with Chennai-based Iswarya Fertility Center raising roughly $37 million, about Rs 350 crore, from global healthcare investor OrbiMed Asia.

The fertility care provider currently runs more than 85 centres spread across eight states. With the new funding, Iswarya plans to establish additional centres in both existing and underserved markets while strengthening its clinical infrastructure and digital capabilities.

Embryology talent has been identified as another priority area, with part of the funding set aside to expand the company’s pipeline of trained embryologists — a resource that has often constrained how quickly fertility chains can scale into smaller cities. ‘We will invest in our people, technology and patient experience,’ said managing director Arun Muthuvel.

Veda Corporate Advisors advised Iswarya and its promoters on the transaction. The firm’s managing director, VP Rajan, said the deal ‘drew strong interest from marquee investors,’ underscoring how global capital continues to back India’s reproductive healthcare sector despite a broader slowdown in dealmaking elsewhere.

Iswarya’s raise adds to a string of large healthcare funding rounds in India this year, with fertility and reproductive care standing out as a category that has kept attracting marquee global investors.